Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rolph Timothy
Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Young Jonathan
Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lamy Patrick
Akero Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Akero Therapeutics | 8-K: Akero Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Akero Therapeutics | 10-K: FY2024 Annual Report
Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Yale Catriona
Akero Therapeutics | SCHEDULE 13G/A: Others
Akero Therapeutics | SCHEDULE 13G/A: Others
Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cheng Andrew
Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Graham G. Walmsley
Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rolph Timothy
Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Young Jonathan
Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Yale Catriona
Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Yale Catriona
Akero Therapeutics | 8-K: Current report
Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rolph Timothy
Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lamy Patrick
Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cheng Andrew
Akero Therapeutics | 424B5: Prospectus